首頁 > 市場調查報告書 > 醫療設備

體外診斷癌症癌症診斷

市場調查報告書

商品編碼

1386474

甲狀腺癌診斷市場報告：2030 年趨勢、預測與競爭分析

Thyroid Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: 2023年10月11日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

甲狀腺癌診斷的趨勢和預測

預計到 2030 年，全球甲狀腺癌診斷市場將達到 76 億美元，2024 年至 2030 年年複合成長率為 5.5%。該市場的主要促進因素是甲狀腺癌盛行率的增加、對即時診斷和治療的日益關注以及對甲狀腺癌的認知不斷提高。全球甲狀腺癌診斷市場前景廣闊，醫院、附屬實驗室、獨立診斷實驗室、診斷影像中心和癌症研究實驗室市場存在商機。

甲狀腺癌診斷市場洞察

Lucintel 預測，由於對高解析度和即時影像檢查的需求不斷增加，影像檢查仍將是最大的細分市場。

在這個市場中，由於醫院診斷癌症患者數量的增加、消費者意識的提高以及對全球醫療基礎設施投資的增加，醫院在預測期內將繼續成為最大的細分市場。

由於美國甲狀腺癌盛行率不斷上升、醫療保健支出增加以及政府在認知、診斷和治療方面的積極配合措施，美國可能仍然是最大的地區。

本報告回答了 11 個關鍵問題：

Q.1. 細分市場中最有前途和高成長的機會是什麼？
Q.2.哪個細分市場將以更快的速度成長？為什麼？
Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和業務風險是什麼？
Q.5. 這個市場的商業風險和競爭威脅是什麼？
Q.6.這個市場有哪些新趨勢？為什麼？
Q.7.市場客戶需求有何改變？
Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

宏觀經濟趨勢（2018-2023）與預測（2024-2030）
全球甲狀腺癌診斷市場趨勢（2018-2023）與預測（2024-2030）
按產品類型分類的全球甲狀腺癌診斷市場
- 裝置
- 消耗品及配件
按測試類型分類的全球甲狀腺癌診斷市場
- 影像檢查
- 切片檢查
- 驗血
- 其他
按最終用途分類的全球甲狀腺癌診斷市場
- 醫院
- 相關研究所
- 獨立診斷實驗室
- 影像診斷中心
- 癌症研究所
- 其他

第4章 2018-2030年分地區市場趨勢及預測分析

按地區分類的全球甲狀腺癌診斷市場
北美甲狀腺癌診斷市場
歐洲甲狀腺癌診斷市場
亞太甲狀腺癌診斷市場
其他地區甲狀腺癌診斷市場

第5章競爭分析

產品系列分析
營運整合
波特五力分析

第6章成長機會與策略分析

成長機會分析
- 按產品類型分類的全球甲狀腺癌診斷市場成長機會
- 按測試類型分類的全球甲狀腺癌診斷市場成長機會
- 全球甲狀腺癌診斷市場最終用途的成長機會
- 全球甲狀腺癌診斷市場按地區成長機會
全球甲狀腺癌診斷市場新趨勢
戰略分析
- 新產品開發
- 擴大全球甲狀腺癌診斷市場的能力
- 全球甲狀腺癌診斷市場的合併、收購與合資企業
- 認證和許可

第7章主要企業概況

Abbott
Hoffmann-La Roche
Thermo Fisher Scientific
Siemens Healthcare
Bio-Rad Laboratories
General Electric
Koninklijke Philips
Toshiba Corporation
Agilent Technologies
Illumina

簡介目錄

Thyroid Cancer Diagnostic Trends and Forecast

The future of the global thyroid cancer diagnostic market looks promising with opportunities in the hospital, associated lab, independent diagnostic laboratory, diagnostic imaging center, and cancer research institute markets. The global thyroid cancer diagnostic market is expected to reach an estimated $7.6 billion by 2030 with a CAGR of 5.5% from 2024 to 2030. The major drivers for this market are the increasing incidence of thyroid cancer, growing focus on real time diagnosis and treatment, and rising awareness towards thyroid cancer.

A more than 150-page report is developed to help in your business decisions.

Thyroid Cancer Diagnostic by Segment

The study includes a forecast for the global thyroid cancer diagnostic by product type, test type, end use, and region.

Thyroid Cancer Diagnostic Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

Instruments
Consumables & Accessories

Thyroid Cancer Diagnostic Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

Imaging Test
Biopsy
Blood Test
Others

Thyroid Cancer Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

Hospital
Associated Labs
Independent Diagnostic Laboratories
Diagnostic Imaging Centers
Cancer Research Institutes
Others

Thyroid Cancer Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

North America
Europe
Asia Pacific
The Rest of the World

List of Thyroid Cancer Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies thyroid cancer diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the thyroid cancer diagnostic companies profiled in this report include-

Abbott
Hoffmann-La Roche
Thermo Fisher Scientific
Siemens Healthcare
Bio-Rad Laboratories
General Electric
Koninklijke Philips
Toshiba Corporation
Agilent Technologies
Illumina

Thyroid Cancer Diagnostic Market Insights

Lucintel forecasts that imaging test will remain the largest segment due to the increasing demand of high resolution and real time image testing.

Within this market, hospitals will remain the largest segmnt over the forecast period due to growing inflow of cancer diagnosis patient in hospitals, increasing consumer awareness, and growing investments in healthcare infrastructure across the globe.

North America will remain the largest region due to increasing prevalence of thyroid cancer, rising healthcare expenditure, and favourable government initiative in the US for awareness, diagnostic and treatment.

Features of the Global Thyroid Cancer Diagnostic Market

Market Size Estimates: Thyroid cancer diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Thyroid cancer diagnostic market size by product type, test type, end use, and region in terms of value ($B).

Regional Analysis: Thyroid cancer diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, test types, end uses, and regions for the thyroid cancer diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the thyroid cancer diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the thyroid cancer diagnostic market size?

Answer: The global thyroid cancer diagnostic market is expected to reach an estimated $7.6 billion by 2030.

Q.2 What is the growth forecast for thyroid cancer diagnostic market?

Answer: The global thyroid cancer diagnostic market is expected to grow with a CAGR of 5.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the thyroid cancer diagnostic market?

Answer: The major drivers for this market are the increasing incidence of thyroid cancer, growing focus on real time diagnosis and treatment, and rising awareness towards thyroid cancer.

Q4. What are the major segments for thyroid cancer diagnostic market?

Answer: The future of the thyroid cancer diagnostic market looks promising with opportunities in the hospital, associated lab, independent diagnostic laboratory, diagnostic imaging center, and cancer research institute markets.

Q5. Who are the key thyroid cancer diagnostic market companies?

Answer: Some of the key thyroid cancer diagnostic companies are as follows:

Abbott
Hoffmann-La Roche
Thermo Fisher Scientific
Siemens Healthcare
Bio-Rad Laboratories
General Electric
Koninklijke Philips
Toshiba Corporation
Agilent Technologies
Illumina

Q6. Which thyroid cancer diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that imaging test will remain the largest segment due to the increasing demand of high resolution and real time image testing.

Q7. In thyroid cancer diagnostic market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to increasing prevalence of thyroid cancer, rising healthcare expenditure, and favourable government initiative in the US for awareness, diagnostic and treatment.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the thyroid cancer diagnostic market by product type (instruments and consumables & accessories), test type (imaging test, biopsy, blood test, and others), end use (hospital, associated labs, independent diagnostic laboratories, diagnostic imaging centers, cancer research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Global Thyroid Cancer Diagnostic Market : Market Dynamics

2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Thyroid Cancer Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Thyroid Cancer Diagnostic Market by Product Type
- 3.3.1: Instruments
- 3.3.2: Consumables & Accessories
3.4: Global Thyroid Cancer Diagnostic Market by Test Type
- 3.4.1: Imaging Test
- 3.4.2: Biopsy
- 3.4.3: Blood Test
- 3.4.4: Others
3.5: Global Thyroid Cancer Diagnostic Market by End Use
- 3.5.1: Hospital
- 3.5.2: Associated Labs
- 3.5.3: Independent Diagnostic Laboratories
- 3.5.4: Diagnostic Imaging Centers
- 3.5.5: Cancer Research Institutes
- 3.5.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

4.1: Global Thyroid Cancer Diagnostic Market by Region
4.2: North American Thyroid Cancer Diagnostic Market
- 4.2.1: North American Thyroid Cancer Diagnostic Market by Test Type: Imaging Test, Biopsy, Blood Test, and Others
- 4.2.2: North American Thyroid Cancer Diagnostic Market by End Use: Hospital, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, and Others
4.3: European Thyroid Cancer Diagnostic Market
- 4.3.1: European Thyroid Cancer Diagnostic Market by Test Type: Imaging Test, Biopsy, Blood Test, and Others
- 4.3.2: European Thyroid Cancer Diagnostic Market by End Use: Hospital, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, and Others
4.4: APAC Thyroid Cancer Diagnostic Market
- 4.4.1: APAC Thyroid Cancer Diagnostic Market by Test Type: Imaging Test, Biopsy, Blood Test, and Others
- 4.4.2: APAC Thyroid Cancer Diagnostic Market by End Use: Hospital, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, and Others
4.5: ROW Thyroid Cancer Diagnostic Market
- 4.5.1: ROW Thyroid Cancer Diagnostic Market by Test Type: Imaging Test, Biopsy, Blood Test, and Others
- 4.5.2: ROW Thyroid Cancer Diagnostic Market by End Use: Hospital, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, and Others

5. Competitor Analysis

5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

6.1: Growth Opportunity Analysis
- 6.1.1: Growth Opportunities for the Global Thyroid Cancer Diagnostic Market by Product Type
- 6.1.2: Growth Opportunities for the Global Thyroid Cancer Diagnostic Market by Test Type
- 6.1.3: Growth Opportunities for the Global Thyroid Cancer Diagnostic Market by End Use
- 6.1.4: Growth Opportunities for the Global Thyroid Cancer Diagnostic Market by Region
6.2: Emerging Trends in the Global Thyroid Cancer Diagnostic Market
6.3: Strategic Analysis
- 6.3.1: New Product Development
- 6.3.2: Capacity Expansion of the Global Thyroid Cancer Diagnostic Market
- 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Thyroid Cancer Diagnostic Market
- 6.3.4: Certification and Licensing